Cat. No.: DIA-0231147
Product Information | |
---|---|
CAS No. | 950736-05-7 |
Formula | C29H24F3N5O |
Molecular Weight | 515.53 |
SMILES | CN(C)CC1=CC=C(C=C1)C2=C3N=CC=C([N]3N=C2)C4=CC(=CC=C4)NC(=O)C5=CC=CC(=C5)C(F)(F)F |
Target | PKCα, IKKβ, and PI3Kα. |
Product Description | B-Raf IN 1 is an inhibitor of Raf wih IC50 values of 24 nM and 25 nM for B-Raf and C-Raf respectively. It is selective over 13 other kinases, including PKCα, IKKβ, and PI3Kα. |
Format & Storage | |
---|---|
Purity | > 99% |
Shipping | Shipped on dry ice. |
Storage | Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.